Purpose To present a case of struma ovarii with a typical features and synchronous primary
thyroid carcinoma and review the available literature to guide diagnosis and management of …

Aims Struma ovarii (SO) are rare, accounting for 0.3–1% of ovarian tumours, and include
benign and malignant lesions. In most cases, histology is not predictive of clinical outcome …

Struma ovarii is a rare variety of specialized monodermal mature ovarian teratoma, it is
composed predominantly of thyroid tissue. Ascites is present in one third of patients. The …

Aim To evaluate the clinico‐pathologic features, treatment options, prognostic factors, and
survival outcomes of malignant struma ovarii based on a systematic literature review in …

Malignant struma ovarii (MSO) is a rare malignant ovarian germ cell tumor that has been
scarcely reported by thyroid surgeons focusing on treatment. There are no golden standards …

Purpose Struma ovarii (SO) is a highly specialized ovarian teratoma, consisting of thyroid
tissue. Rarely, carcinomas histologically identical to their thyroid counterparts may occur …

Papillary carcinomas of thyroid type rarely arise within struma ovarii. There are limited data
on the immunohistochemical and molecular features of these tumors. Three cases of …

Background Malignant struma ovarii (MSO) is a very rare, germ cell tumor of the ovary,
histologically identical to differentiated thyroid cancers. Struma ovarii (SO) is difficult to …

Background: Since malignant struma ovarii is a very rare disease, its carcinogenic
mechanism has not been elucidated. Here, we sought to identify the genetic lesions that …

The origin of most ovarian tumors is undefined. Here, we report development of a novel
mouse model in which conditional inactivation of the tumor suppressor gene Rb1 in oocytes …